MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11060-022-04037-0

Медицинская библиотека · Journal of neuro-oncology · 2022

Radiation myelopathy following stereotactic body radiation therapy for spine metastases.

Ong Wee Loon, Wong Shun, Soliman Hany, Myrehaug Sten, Tseng Chia-Lin, Detsky Jay, Husain Zain, Maralani Pejman, Ma Lijun, Lo Simon S, Sahgal Arjun

СтатьяОбзорПеревод в очереди

Аннотация

PURPOSE: Stereotactic body radiation therapy (SBRT) is now considered a standard of care treatment option in the management of spine metastases. One of the most feared complications of spine SBRT is radiation myelopathy (RM).

METHODS

We provided a narrative review of RM following spine SBRT based on review of the published literature, including data on spinal cord dose constraints associated with the risk of RM, strategies to mitigate the risk, and management options for RM.

RESULTS

There are limited published data of cases of RM following spine SBRT with detailed spinal cord dosimetry. The HyTEC report provided recommendations for the point maximal dose (Dmax) for the spinal cord that is associated with a < 5% risk of RM for 1-5 fractions spine SBRT. In the setting of spine SBRT reirradiation after previous conventional external beam radiation therapy (cEBRT), factors associated with RM are: SBRT spinal cord Dmax, cumulative spinal cord Dmax, and the time interval between previous RT and SBRT reirradiation. There are various strategies to mitigate the risk of RM, including accurate delineation of the spinal cord (or thecal sac), strict adherence to the recommended spinal cord dose constraints, and robust treatment immobilisation set-up and delivery. Limited effective treatment options are available for patients who develop RM, and these include corticosteroids, hyperbaric oxygen, and bevacizumab; however, none have been supported by high quality evidence.

CONCLUSION

RM is a rare but devastating complication following SBRT for spine metastases. There are strategies to minimise the risk of RM to ensure safe delivery of spine SBRT.

Для цитирования: Ong Wee Loon, Wong Shun, Soliman Hany, Myrehaug Sten, Tseng Chia-Lin, Detsky Jay, Husain Zain, Maralani Pejman, Ma Lijun, Lo Simon S, Sahgal Arjun. Radiation myelopathy following stereotactic body radiation therapy for spine metastases.. Journal of neuro-oncology. 2022. DOI: 10.1007/s11060-022-04037-0.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.